Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


NEOPLASM PROGRESSION side effect

What is NEOPLASM PROGRESSION ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   NEOPLASM PROGRESSION and Recently Reported Side Effects   NEOPLASM PROGRESSION and 15 most Active Side Effect polls   NEOPLASM PROGRESSION and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with NEOPLASM PROGRESSION

ACTONEL  ALIMTA  ARSENIC  AVASTIN  AVONEX  BETAMETHASONE  BETASERON  BEVACIZUMAB  BEXXAR  CAPECITABINE  CISPLATIN  CLARAVIS  ENDOXAN  ERLOTINIB  EVISTA  FLAGYL  FORTEO  GEMCITABINE  GENOTROPIN  GLEEVEC  GLIADEL  HUMATROPE  INHALED  INNOHEP  IRESSA  ISOTRETINOIN  LYSODREN  NUTROPIN  PACLITAXEL  PRIALT  PRINIVIL  PROCRIN  PROCRIT  PROVIGIL  REBIF  REVLIMID  RITUXAN  SAIZEN  SEROQUEL  SUTENT  TARCEVA  TEMODAL  TEMODAR  TEMOZOLOMIDE  THALOMID  THYROGEN  VELCADE  XELODA  ZEVALIN  ZIAGEN  ZOMETA  


Zometa Side Effects Report #5670758-2
Health Professional from UNITED STATES reported ZOMETA problem on Mar 13, 2008. Male patient was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . ZOMETA dosage: 4 MG, UNK. Patient died.

Provigil Side Effects Report #5677941-0
PROVIGIL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2005. Female patient, 33 years of age, weighting 145.0 lb, was diagnosed with autonomic neuropathy and was treated with PROVIGIL. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . PROVIGIL dosage: 400 MG QD ORAL. During the same period patient was treated with FLORINEF, WELLBUTRIN, KERLONE. Patient recovered.

Nutropin Side Effects Report #5645041-1
Physician from UNITED STATES reported NUTROPIN problem on Feb 19, 2008. Male patient, weighting 93.70 lb, was diagnosed with hypopituitarism and was treated with NUTROPIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . NUTROPIN dosage: 1.4 MG, QD. During the same period patient was treated with LEVOTHYROXINE. Patient recovered.

Zevalin Side Effects Report #5590408-3
ZEVALIN problem was reported by a Physician from UNITED STATES on Dec 26, 2007. Female patient was diagnosed with diffuse large b-cell lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, off label use, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXAN. Patient died.


Nutropin Side Effects Report #5595063-4
Physician from UNITED STATES reported NUTROPIN problem on Jan 07, 2008. Male patient was treated with NUTROPIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . NUTROPIN dosage: 1.4 MG, QD. Patient recovered.

Revlimid Side Effects Report #5633815-2
REVLIMID problem was reported by a Physician from UNITED STATES on Nov 16, 2007. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL; X21 DAYS/28 DAYS, ORAL. Patient recovered.

Revlimid Side Effects Report #5639485-1
Consumer or non-health professional from UNITED STATES reported REVLIMID problem on Dec 21, 2007. Male patient, 68 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DEXAMETHASONE, COUMADIN, PENICILLIN, ACYCLOVIR, LEVOTHYROXINE, METHADONE, NORTRIPTYLINE, VITAMIN. Patient recovered.

Revlimid Side Effects Report #5641897-7
REVLIMID problem was reported by a Pharmacist from UNITED STATES on Oct 12, 2007. Male patient, 58 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . REVLIMID dosage: 10 MG, DAILY X 21 DAYS, ORAL. During the same period patient was treated with VINCRISTINE, DOXEL, DECADRON. Patient recovered.

Revlimid Side Effects Report #5641936-3
Physician from UNITED STATES reported REVLIMID problem on Nov 26, 2007. Female patient, 76 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . REVLIMID dosage: 5 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.


Rebif Side Effects Report #5567630-5
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 03, 2007. Female patient, 37 years of age, weighting 204.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, procedural pain, . REBIF dosage: unknown. During the same period patient was treated with SYNTHROID, NEXIUM. Patient recovered.

Avonex Side Effects Report #5568486-7
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Dec 04, 2007. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.

Genotropin Side Effects Report #5514697-6
GENOTROPIN problem was reported by a Consumer or non-health professional from GERMANY on Nov 06, 2007. Male patient, weighting 154.3 lb, was diagnosed with hypopituitarism and was treated with GENOTROPIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, pituitary tumour benign, . GENOTROPIN dosage: DAILY DOSE:1.5MG-FREQ:DAILY. During the same period patient was treated with TESTOSTERONE. Patient recovered.

Gliadel Side Effects Report #5526709-4
Health Professional from UNITED STATES reported GLIADEL problem on Feb 09, 2007. Female patient was treated with GLIADEL. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, postoperative wound infection, . GLIADEL dosage: unknown. Patient was hospitalized. Patient died on 11/23/2006.

Prialt Side Effects Report #5483216-5
PRIALT problem was reported by a Physician from AUSTRIA on Sept 27, 2007. Male patient, 54 years of age, weighting 147.7 lb, was diagnosed with cancer pain and was treated with PRIALT. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . PRIALT dosage: unknown. During the same period patient was treated with NEURONTIN, NOVALGIN, TRYPTIZOL, DEFLAMAT. Patient died on 12/31/2006.


Prialt Side Effects Report #5491434-5
Physician from UNITED KINGDOM reported PRIALT problem on Oct 03, 2007. Male patient, 54 years of age, weighting 147.7 lb, was diagnosed with cancer pain and was treated with PRIALT. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . PRIALT dosage: unknown. During the same period patient was treated with NEURONTIN, NOVALGIN, TRYPTIZOL, DEFLAMAT. Patient died on 12/31/2006.

Isotretinoin Side Effects Report #5500282-9
ISOTRETINOIN problem was reported by a Pharmacist from UNITED STATES on Oct 16, 2007. Female patient was diagnosed with neuroblastoma and was treated with ISOTRETINOIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, off label use, . ISOTRETINOIN dosage: 40 MG, BID. Patient died on 01/13/2007.

Claravis Side Effects Report #5500428-2
Physician from UNITED STATES reported CLARAVIS problem on Oct 17, 2007. Male patient was diagnosed with pinealoblastoma and was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, pinealoblastoma, . CLARAVIS dosage: unknown. During the same period patient was treated with PEPCID, TYLENOL, DEXAMETHASONE, FOLIC ACID, ZOLOFT. Patient died.

Zometa Side Effects Report #5469653-3
ZOMETA problem was reported by a Health Professional from UNITED STATES on Sept 26, 2007. Male patient, 57 years of age, weighting 220.0 lb, was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . ZOMETA dosage: 4MG Q 90 DAYS IV. During the same period patient was treated with LOTREL, MINOCYCLINE, LEXAPRO, ZOCOR, DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5394701-9
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on July 10, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . BEVACIZUMAB dosage: 850 MG, Q3W. During the same period patient was treated with ERLOTINIB, METFORMIN, ACETAMINOPHEN, CITALOPRAM. Patient died on 07/04/2007.


Betaseron Side Effects Report #5400801-7
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Male patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, prostate examination abnormal, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5394701-9
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on July 10, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . BEVACIZUMAB dosage: 850 MG, Q3W. During the same period patient was treated with ERLOTINIB, METFORMIN, ACETAMINOPHEN, CITALOPRAM. Patient died on 07/04/2007.

Betaseron Side Effects Report #5400801-7
BETASERON problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Male patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with BETASERON. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, prostate examination abnormal, . BETASERON dosage: unknown. Patient was hospitalized. Patient recovered.

Humatrope Side Effects Report #5729449-1
Physician from UNITED KINGDOM reported HUMATROPE problem on Apr 24, 2008. Male patient, 54 years of age, was diagnosed with growth hormone deficiency and was treated with HUMATROPE. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . HUMATROPE dosage: unknown. Patient died.

Avastin Side Effects Report #5753963-6
AVASTIN problem was reported by a Physician from UNITED KINGDOM on May 15, 2008. Female patient, 36 years of age, weighting 145.5 lb, was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, skin ulcer, . AVASTIN dosage: 10 MG/KG, UNK. During the same period patient was treated with TAXOL, TAGAMET, ZOPHREN, POLARAMINE. Patient recovered.

Xeloda Side Effects Report #5693804-9
Physician from FRANCE reported XELODA problem on Feb 01, 2000. Female patient, 70 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, rectal haemorrhage, . XELODA dosage: unknown. Patient died.

Avastin Side Effects Report #5720227-6
AVASTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 20, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, white blood cell count decreased, . AVASTIN dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOTERE, GEMZAR, ERLOTINIB. Patient recovered.

Velcade Side Effects Report #5724944-3
Physician from JAPAN reported VELCADE problem on Apr 16, 2008. Female patient, 78 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, pneumonia, . VELCADE dosage: 1 MG/M2, INTRAVENOUS. Patient died on 04/07/2008.

Zometa Side Effects Report #5350431-0
ZOMETA problem was reported by a Health Professional from UNITED STATES on June 05, 2007. Male patient, 41 years of age, weighting 160.9 lb, was diagnosed with brain neoplasm, osteoporosis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, nuclear magnetic resonance imaging brain abnormal, somnolence, . ZOMETA dosage: 4MG Q12 WEEKS IV. During the same period patient was treated with DILANTIN. Patient was hospitalized. Patient recovered.

Evista Side Effects Report #5372487-1
Physician from UNITED STATES reported EVISTA problem on June 14, 2007. Female patient, 51 years of age, was diagnosed with osteoporosis and was treated with EVISTA. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . EVISTA dosage: 60 MG, UNK. During the same period patient was treated with LAMICTAL. Patient recovered.

Velcade Side Effects Report #5316514-6
VELCADE problem was reported by a Physician from GERMANY on Apr 17, 2007. Male patient, 58 years of age, weighting 269.0 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, pancytopenia, . VELCADE dosage: 2.00 MG, INTRAVENOUS. Patient died on 03/26/2007.

Temodal Side Effects Report #5317875-4
Physician from JAPAN reported TEMODAL problem on Apr 27, 2007. Male patient, 54 years of age, weighting 163.1 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . TEMODAL dosage: 75 MG/M2; 150 MG/M2 : QD: PO. During the same period patient was treated with EXCEGRAN, RINDERON, GASTER, PURSENNID. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5255957-6
FORTEO problem was reported by a Physician from GERMANY on Feb 21, 2007. Female patient, 78 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . FORTEO dosage: unknown. Patient died.

Iressa Side Effects Report #5263741-2
Consumer or non-health professional from UNITED STATES reported IRESSA problem on May 21, 2004. Female patient, 81 years of age, was diagnosed with non-small cell lung cancer and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . IRESSA dosage: 250 MG DAILY PO. Patient recovered.

Procrit Side Effects Report #5265843-3
PROCRIT problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2007. Female patient, 60 years of age, weighting 115.0 lb, was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . PROCRIT dosage: unknown. Patient died on 11/27/2005.

Rituxan Side Effects Report #5269662-3
Physician from JAPAN reported RITUXAN problem on Mar 01, 2007. Male patient, 59 years of age, weighting 130.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, obstruction gastric, pancreatic disorder, . RITUXAN dosage: 375 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.

Zometa Side Effects Report #5677265-1
ZOMETA problem was reported by a Health Professional from UNITED STATES on Mar 21, 2008. Male patient, 53 years of age, weighting 220.5 lb, was diagnosed with osteoporosis and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, neoplasm progression, . ZOMETA dosage: 4MG Q 90 DAYS IV. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5618840-X
Physician from UNITED STATES reported REVLIMID problem on Jan 28, 2008. Male patient, 49 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: multiple myeloma, neoplasm progression, renal failure acute, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/25/2007.

Velcade Side Effects Report #5632249-4
VELCADE problem was reported by a Physician from JAPAN on Feb 01, 2008. Male patient, 61 years of age, weighting 94.80 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 01/31/2008.

Seroquel Side Effects Report #5589996-2
Consumer or non-health professional from UNITED STATES reported SEROQUEL problem on Jan 11, 2008. Female patient, 26 years of age, was diagnosed with convulsion and was treated with SEROQUEL. After drug was administered, patient experienced the following problems/side effects: neoplasm progression, . SEROQUEL dosage: unknown. During the same period patient was treated with TOPAMAX, CYMBALTA. Patient died on 09/13/2007.

Gemcitabine Side Effects Report #5591371-1
GEMCITABINE problem was reported by a Health Professional from UNITED STATES on Jan 11, 2008. Female patient, 54 years of age, weighting 175.5 lb, was diagnosed with lung neoplasm malignant and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: metastases to spine, neoplasm progression, . GEMCITABINE dosage: 1520 MG DAY 1 AND 8 IV. During the same period patient was treated with CAPECITABINE, OXYCODONE, OXYCONTIN. Patient was hospitalized. Patient recovered.

Genotropin Side Effects Report #5596847-9
Consumer or non-health professional from UNITED KINGDOM reported GENOTROPIN problem on Jan 11, 2008. Male patient, 45 years of age, weighting 202.8 lb, was diagnosed with hypopituitarism and was treated with GENOTROPIN. After drug was administered, patient experienced the following problems/side effects: craniopharyngioma, neoplasm progression, . GENOTROPIN dosage: unknown. During the same period patient was treated with TESTOSTERONE, DDAVP. Patient recovered.

Revlimid Side Effects Report #5645782-6
REVLIMID problem was reported by a Health Professional from UNITED STATES on Dec 12, 2007. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: bone pain, neoplasm progression, tumour marker increased, white blood cell count decreased, . REVLIMID dosage: 20 MG, 2 IN 1 D, ORAL; 10 MG, DAILY X 21 DAYS, ORAL 5MG-10MG, DAILY, ORAL. Patient recovered.

Thyrogen Side Effects Report #5549672-9
Physician from UNITED STATES reported THYROGEN problem on Nov 20, 2007. Female patient, 82 years of age, was diagnosed with metastasis and was treated with THYROGEN. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, neoplasm progression, respiratory failure, thyroid cancer, . THYROGEN dosage: MG ONCE IM. Patient died on 01/01/2003.

Prinivil Side Effects Report #5566702-9
PRINIVIL problem was reported by a Physician from GERMANY on Dec 12, 2007. Female patient, 70 years of age, was diagnosed with adrenocortical carcinoma and was treated with PRINIVIL. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, neoplasm progression, psychomotor hyperactivity, sleep disorder, . PRINIVIL dosage: unknown. During the same period patient was treated with LYSODREN. Patient was hospitalized. Patient died.

Temodal Side Effects Report #5567364-7
Physician from JAPAN reported TEMODAL problem on Dec 07, 2007. Male patient, 60 years of age, weighting 147.7 lb, was diagnosed with disease recurrence, glioblastoma multiforme and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, neoplasm progression, pneumonia aspiration, sepsis, vomiting, white blood cell count decreased, . TEMODAL dosage: 15 MG/M2; QD; PO; 100 MG/M2; QD; PO; 150 MG/M2; QD; PO; 150 MG/M2; PO. During the same period patient was treated with EXCEGRAN. Patient recovered.

Prinivil Side Effects Report #5570970-7
PRINIVIL problem was reported by a Physician from UNITED STATES on Dec 12, 2007. Female patient, 70 years of age, was diagnosed with adrenocortical carcinoma and was treated with PRINIVIL. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, neoplasm progression, psychomotor hyperactivity, sleep disorder, . PRINIVIL dosage: unknown. During the same period patient was treated with LYSODREN. Patient was hospitalized. Patient died.

Claravis Side Effects Report #5575526-8
Physician from UNITED STATES reported CLARAVIS problem on Dec 13, 2007. Male patient, child 2 years of age, was diagnosed with brain neoplasm malignant, off label use and was treated with CLARAVIS. After drug was administered, patient experienced the following problems/side effects: brain neoplasm, neoplasm progression, refusal of treatment by relative, . CLARAVIS dosage: 20 MG, BID, ORAL. During the same period patient was treated with TEMODAR. Patient recovered.

Thyrogen Side Effects Report #5510793-8
THYROGEN problem was reported by a Physician from UNITED STATES on Oct 31, 2007. Female patient, 82 years of age, was diagnosed with high frequency ablation and was treated with THYROGEN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, neoplasm progression, . THYROGEN dosage: MG ONCE IM. Patient died on 01/01/2003.

Temodal Side Effects Report #5527909-X
Physician from JAPAN reported TEMODAL problem on Nov 20, 2007. Male patient, 24 years of age, weighting 94.80 lb, was diagnosed with medulloblastoma recurrent and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: disease progression, neoplasm progression, pneumonia, respiratory disorder, staphylococcal infection, . TEMODAL dosage: PO; 200 MG/M2;QD; PO. During the same period patient was treated with RANIMUSTINE, METHOTREXATE, IFOSFAMIDE, LOXONIN, PREDNISOLONE. Patient was hospitalized. Patient died on 02/21/2007.

Prialt Side Effects Report #5480208-7
PRIALT problem was reported by a Physician from UNITED KINGDOM on Sept 19, 2007. Male patient, 54 years of age, weighting 147.7 lb, was treated with PRIALT. After drug was administered, patient experienced the following problems/side effects: angiosarcoma, neoplasm progression, . PRIALT dosage: unknown. During the same period patient was treated with NEURONTIN, NOVALGIN, TRYPTIZOL, DEFLAMAT. Patient died on 12/31/2006.

Flagyl Side Effects Report #5499210-4
Consumer or non-health professional from reported FLAGYL problem on Oct 15, 2007. Female patient, 86 years of age, was diagnosed with atrial fibrillation and was treated with FLAGYL. After drug was administered, patient experienced the following problems/side effects: haematuria, neoplasm progression, . FLAGYL dosage: unknown. During the same period patient was treated with CORDARONE, COUMADIN, INNOHEP, LEVOTHYROX, ROCEPHIN. Patient was hospitalized. Patient died on 03/24/2007.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about NEOPLASM PROGRESSION side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about NEOPLASM PROGRESSION